These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30809862)

  • 1. Biphasic hydroxyapatite and ß-tricalcium phosphate biomaterial behavior in a case series of maxillary sinus augmentation in humans.
    Olaechea A; Mendoza-Azpur G; O Valle F; Padial-Molina M; Martin-Morales N; Galindo-Moreno P
    Clin Oral Implants Res; 2019 Apr; 30(4):336-343. PubMed ID: 30809862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monophasic ß-TCP vs. biphasic HA/ß-TCP in two-stage sinus floor augmentation procedures - a prospective randomized clinical trial.
    Jelusic D; Zirk ML; Fienitz T; Plancak D; Puhar I; Rothamel D
    Clin Oral Implants Res; 2017 Oct; 28(10):e175-e183. PubMed ID: 27683073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Algae-derived hydroxyapatite behavior as bone biomaterial in comparison with anorganic bovine bone: A split-mouth clinical, radiological, and histologic randomized study in humans.
    Galindo-Moreno P; Padial-Molina M; Lopez-Chaichio L; Gutiérrez-Garrido L; Martín-Morales N; O'Valle F
    Clin Oral Implants Res; 2020 Jun; 31(6):536-548. PubMed ID: 32072685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sinus Floor Augmentation Comparing an In Situ Hardening Biphasic Calcium Phosphate (Hydroxyapatite/β-Tricalcium Phosphate) Bone Graft Substitute with a Particulate Biphasic Calcium Phosphate (Hydroxyapatite/β-Tricalcium Phosphate) Bone Graft Substitute: An Experimental Study in Sheep.
    Wildburger A; Bubalo V; Magyar M; Nagursky H; Jakse N; Schmelzeisen R; Sauerbier S
    Tissue Eng Part C Methods; 2017 Jul; 23(7):404-411. PubMed ID: 28605989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histologic and histomorphometric assessment of sinus-floor augmentation with beta-tricalcium phosphate alone or in combination with pure-platelet-rich plasma or platelet-rich fibrin: A randomized clinical trial.
    Cömert Kılıç S; Güngörmüş M; Parlak SN
    Clin Implant Dent Relat Res; 2017 Oct; 19(5):959-967. PubMed ID: 28745027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Human Clinical, Histological, Histomorphometrical, and Radiographical Study on Biphasic HA-Beta-TCP 30/70 in Maxillary Sinus Augmentation.
    Mangano C; Sinjari B; Shibli JA; Mangano F; Hamisch S; Piattelli A; Perrotti V; Iezzi G
    Clin Implant Dent Relat Res; 2015 Jun; 17(3):610-8. PubMed ID: 24004190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparative Study with Biphasic Calcium Phosphate to Deproteinized Bovine Bone in Maxillary Sinus Augmentation: A Prospective Randomized and Controlled Clinical Trial.
    Oh JS; Seo YS; Lee GJ; You JS; Kim SG
    Int J Oral Maxillofac Implants; 2019; 34(1):233–242. PubMed ID: 30521656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of Straumann Bone Ceramic in a maxillary sinus floor elevation procedure: a clinical, radiological, histological and histomorphometric evaluation with a 6-month healing period.
    Frenken JW; Bouwman WF; Bravenboer N; Zijderveld SA; Schulten EA; ten Bruggenkate CM
    Clin Oral Implants Res; 2010 Feb; 21(2):201-8. PubMed ID: 19958374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volume stability of hydroxyapatite and β-tricalcium phosphate biphasic bone graft material in maxillary sinus floor elevation: a radiographic study using 3D cone beam computed tomography.
    Ohe JY; Kim GT; Lee JW; Al Nawas B; Jung J; Kwon YD
    Clin Oral Implants Res; 2016 Mar; 27(3):348-53. PubMed ID: 25644065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histomorphometric assessment of bone formation in sinus augmentation utilizing a combination of autogenous and hydroxyapatite/biphasic tricalcium phosphate graft materials: at 6 and 9 months in humans.
    Artzi Z; Weinreb M; Carmeli G; Lev-Dor R; Dard M; Nemcovsky CE
    Clin Oral Implants Res; 2008 Jul; 19(7):686-92. PubMed ID: 18492077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sinus augmentation using human mesenchymal stem cells loaded into a beta-tricalcium phosphate/hydroxyapatite scaffold.
    Shayesteh YS; Khojasteh A; Soleimani M; Alikhasi M; Khoshzaban A; Ahmadbeigi N
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Aug; 106(2):203-9. PubMed ID: 18424115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maxillary sinus floor augmentation using biphasic calcium phosphate: a histologic and histomorphometric study.
    Ohayon L
    Int J Oral Maxillofac Implants; 2014; 29(5):1143-8. PubMed ID: 25216141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sinus floor elevation using particulate PLGA-coated biphasic calcium phosphate bone graft substitutes: A prospective histological and radiological study.
    Flichy-Fernández AJ; Blaya-Tárraga JA; O'Valle F; Padial-Molina M; Peñarrocha-Diago M; Galindo-Moreno P
    Clin Implant Dent Relat Res; 2019 Oct; 21(5):895-902. PubMed ID: 30895713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maxillary sinus grafting with biphasic calcium phosphate ceramics: clinical and histologic evaluation in man.
    Mangano C; Perrotti V; Shibli JA; Mangano F; Ricci L; Piattelli A; Iezzi G
    Int J Oral Maxillofac Implants; 2013; 28(1):51-6. PubMed ID: 23377047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maxillary sinus floor augmentation using a beta-tricalcium phosphate (Cerasorb) alone compared to autogenous bone grafts.
    Zijderveld SA; Zerbo IR; van den Bergh JP; Schulten EA; ten Bruggenkate CM
    Int J Oral Maxillofac Implants; 2005; 20(3):432-40. PubMed ID: 15973955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cone Beam Computed Tomography Assessment of Maxillary Sinus Floor Augmentation Using Beta-Tricalcium Phosphate Alone or in Combination with Platelet-Rich Plasma: A Randomized Clinical Trial.
    Kiliç SC; Güngörmüş M
    Int J Oral Maxillofac Implants; 2016; 31(6):1367-1375. PubMed ID: 27861663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological evaluation of maxillary sinus floor augmentation with recombinant human growth and differentiation factor-5-coated β-tricalcium phosphate: results of a multicenter randomized clinical trial.
    Stavropoulos A; Becker J; Capsius B; Açil Y; Wagner W; Terheyden H
    J Clin Periodontol; 2011 Oct; 38(10):966-74. PubMed ID: 21797917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maxillary Sinus Augmentation With Calcium Phosphate Double-Coated Anorganic Bovine Bone: Comparative Multicenter Randomized Clinical Trial With Histological and Radiographic Evaluation.
    Pang KM; Lee JK; Choi SH; Kim YK; Kim BJ; Lee JH
    Implant Dent; 2019 Feb; 28(1):39-45. PubMed ID: 30570584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a new biphasic calcium phosphate for maxillary sinus floor elevation: Micro-CT and histomorphometrical analyses.
    Helder MN; van Esterik FAS; Kwehandjaja MD; Ten Bruggenkate CM; Klein-Nulend J; Schulten EAJM
    Clin Oral Implants Res; 2018 May; 29(5):488-498. PubMed ID: 29638012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the association of blood-derived growth factors to nanostructured carbonated hydroxyapatite contributes to the maxillary sinus floor elevation? A randomized clinical trial.
    de Almeida Barros Mourão CF; Lourenço ES; Nascimento JRB; Machado RCM; Rossi AM; Leite PEC; Granjeiro JM; Alves GG; Calasans-Maia MD
    Clin Oral Investig; 2019 Jan; 23(1):369-379. PubMed ID: 29730707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.